» Articles » PMID: 38469228

Editorial: Heterogeneity in Breast Cancer: Clinical and Therapeutic Implications

Overview
Journal Front Oncol
Specialty Oncology
Date 2024 Mar 12
PMID 38469228
Authors
Affiliations
Soon will be listed here.
References
1.
Apostolou P, Fostira F . Hereditary breast cancer: the era of new susceptibility genes. Biomed Res Int. 2013; 2013:747318. PMC: 3618918. DOI: 10.1155/2013/747318. View

2.
Gucalp A, Traina T, Eisner J, Parker J, Selitsky S, Park B . Male breast cancer: a disease distinct from female breast cancer. Breast Cancer Res Treat. 2018; 173(1):37-48. PMC: 7513797. DOI: 10.1007/s10549-018-4921-9. View

3.
Rosso R, DAlonzo M, Bounous V, Actis S, Cipullo I, Salerno E . Adherence to Adjuvant Endocrine Therapy in Breast Cancer Patients. Curr Oncol. 2023; 30(2):1461-1472. PMC: 9955792. DOI: 10.3390/curroncol30020112. View

4.
Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

5.
Tarantino P, Hamilton E, Tolaney S, Cortes J, Morganti S, Ferraro E . HER2-Low Breast Cancer: Pathological and Clinical Landscape. J Clin Oncol. 2020; 38(17):1951-1962. DOI: 10.1200/JCO.19.02488. View